Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |